Black Bird Biotech, Inc.
BBBT
$0.00
$0.000.00%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | 63.70% | 63.26% | 44.79% | 8.42% | -79.76% |
| Total Depreciation and Amortization | 139.50% | 96.88% | 70.75% | -18.96% | 99.83% |
| Total Amortization of Deferred Charges | -20.08% | -44.99% | -80.68% | -80.68% | 50.00% |
| Total Other Non-Cash Items | -85.22% | -85.83% | -71.10% | -13.55% | 261.65% |
| Change in Net Operating Assets | 116.45% | 819.69% | 320.24% | 253.61% | 265.80% |
| Cash from Operations | 81.84% | 75.64% | 39.43% | -4.04% | -35.98% |
| Capital Expenditure | -- | -- | -- | -- | 197.19% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -800.00% |
| Cash from Investing | -- | -- | -- | -- | 100.00% |
| Total Debt Issued | -43.84% | -36.12% | 99.00% | 31.38% | 17.01% |
| Total Debt Repaid | 65.84% | 63.95% | 64.17% | 44.14% | -255.77% |
| Issuance of Common Stock | -- | -- | -- | -88.09% | -45.15% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 167.74% |
| Cash from Financing | -67.38% | -78.58% | -48.80% | -64.47% | -72.46% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 91.99% | -224.11% | -428.43% | -201.86% | -197.60% |